Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Imposter participants threaten the integrity of health research and the policies and clinical decisions built upon it, according to the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) research published in The BMJ.

A woman partially hiding behind a mask

Eileen Morrow, NIHR Doctoral Clinical Academic Research Fellow at NDORMS said the research community ‘must acknowledge the problem and dedicate resources to testing and implementing safeguards .. to ensure that the data guiding clinical care reflect the real patient voice.’

Imposter participants are individuals who provide deceptive or inaccurate data in order to take part in health research or automated computer ‘bots’ which mimic human behaviour and responses.

The issue has grown in recent years as online recruitment has become central to modern healthcare research and can impact all types of studies, from surveys to randomised controlled trials.

The motivations of imposter participants remain unknown, explained Eileen who conducted the study with colleagues from NDORMS. Although some reports suggest that monetary benefit is a driver, not all studies offer financial incentives, so other motives, such as boredom, curiosity, or even an ideological intent to disrupt research, may also play a role.

Yet their impact is demonstrable. A 2025 review showed that 18 of 23 studies which looked for imposter participants in their data sets, found them, with rates ranging from 3% to a high of 94%.

 

Read the full story on the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences website. 

Similar stories

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.

Robotic hip and knee surgery fails to cut overall risk of repeat surgery

Two major studies from the University of Oxford, Queen Mary University of London and the University of Bristol, have found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.

Oxford medical student takes AI safety message to the Palace of Versailles

Oxford medical student Julian Shellard has presented at an international workshop on the future of Artificial Intelligence (AI) at the Palace of Versailles in Paris, highlighting the important role medical students can play in global conversations on shaping the future of science and medicine.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group at the MRC Weatherall Institute of Molecular Medicine, have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Dunn School publishes new children’s book to mark centenary

The collaboration with Oxford University Press brings the story of the development of Penicillin to a new audience